NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Evaluation of pre-analytical, demographic, behavioural and metabolic variables on fibrinolysis and haemostasis activation markers utilised to assess hypercoagulability.

Author(s): Stegnar M, Cuderman TV, Bozic M

Publication: Clin Chem Lab Med, 2007, Vol. 45, Page 40-6

PubMed ID: 17243913 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the correlation of several preanalytical variables with haemostasis activation markers and fibrinolytic variables in healthy individuals.

Conclusion of Paper

Up to 40% of the variance observed in fibrinolytic variables could be accounted for by several independent associations with preanalytical metabolic variables including BMI, blood pressure, cholesterol and triglyceride levels. In addition, tissue-type plasminogen activator (t-PA) antigen was significantly higher in men than women. Haemostasis activation markers were also significantly influenced by cholesterol levels, as well as age. Importantly, blood specimens collected by a nurse who was untrained in phlebotomy technique showed significantly higher values for all haemostasis activation markers when compared to specimens obtained from the same donors by a trained nurse.

Studies

  1. Study Purpose

    The purpose of this study was to determine the correlation of age, gender, smoking status, body mass index (BMI), blood pressure, cholesterol, and triglyceride levels with fibrinolytic variables (t-PA activity and antigen, plasminogen activator inhibitor-1 (PAI-1) activity and antigen, and euglobulin clot lysis time) and haemostasis activation markers (prothrombin fragment 1 + 2 (F1 + 2), thrombin-antithrombin (TAT) complex, and D-dimer) in healthy individuals. Comparisons were also made between blood specimens collected by a trained and untrained nurse.

    Summary of Findings:

    t-PA antigen was significantly higher in men than women, but there was no effect of smoking status. None of the other fibrinolytic variables or haemostasis activation markers were affected by gender or smoking. However several independent correlations were observed between the fibrinolytic variables and preanalytical metabolic variables. Most significantly, t-PA antigen, PAI activity, and PAI-1 antigen were each associated with BMI and triglyceride levels. t-PA antigen was further influenced by low-density lipoprotein-cholesterol (LDL-C) levels and t-PA activity was significantly associated with high-density lipoprotein-cholesterol (HDL-C) levels. The haemostasis activation markers also showed some significant correlations with preanalytical metabolic and demographic variables. Importantly TAT complex and D-dimer were negatively and positively associated with age, respectively. D-dimer was also significantly influenced by total cholesterol and LDL-C levels, while F1 + 2 was negatively associated with HDL-C levels. Blood specimens collected by a nurse who was untrained in phlebotomy technique showed significantly higher values for all haemostasis activation markers when compared to specimens obtained from the same donors by a trained nurse.

    Biospecimens
    Preservative Types
    • Frozen
    Diagnoses:
    • Normal
    Platform:
    AnalyteTechnology Platform
    Protein ELISA
    Morphology Macroscopic observation
    Peptide ELISA
    Steroid Colorimetric assay
    Lipid Colorimetric assay
    Lipoprotein Colorimetric assay
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Acquisition Method of fluid acquisition Staff trained/experienced in phlebotomy
    Staff untrained/inexperienced in phlebotomy
    Preaquisition Patient age 20-92 y
    Preaquisition Patient gender Female
    Male
    Preaquisition Other drugs Smoker
    Non-smoker
    Preaquisition Blood pressure Various values
    Preaquisition Biomarker level Total cholesterol
    HDL-C
    LDL-C
    Triglycerides
    Biospecimen Aliquots and Components Blood and blood products Serum
    Platelet-poor plasma

You Recently Viewed  

News and Announcements

  • Most Downloaded SOPs in 2024

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • More...